Global Micro-RNA Sequencing and Assay Market Research Report 2024

Publication ID:

PB503241054

Publication Date:

March 22, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

MicroRNA sequencing (miRNA-seq), a type of RNA-Seq, is the use of next-generation sequencing or massively parallel high-throughput DNA sequencing to sequence microRNAs, also called miRNAs. miRNA-seq differs from other forms of RNA-seq in that input material is often enriched for small RNAs. miRNA-seq allows researchers to examine tissue-specific expression patterns, disease associations, and isoforms of miRNAs, and to discover previously uncharacterized miRNAs. Evidence that dysregulated miRNAs play a role in diseases such as cancer has positioned miRNA-seq to potentially become an important tool in the future for diagnostics and prognostics as costs continue to decrease.Like other miRNA profiling technologies, miRNA-Seq has both advantages (sequence-independence, coverage) and disadvantages (high cost, infrastructure requirements, run length, and potential artifacts).
The global Micro-RNA Sequencing and Assay market was valued at US$ 231 million in 2023 and is anticipated to reach US$ 429.3 million by 2030, witnessing a CAGR of 9.8% during the forecast period 2024-2030.
North American market for Micro-RNA Sequencing and Assay is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Micro-RNA Sequencing and Assay is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Micro-RNA Sequencing and Assay in Research Institute is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Micro-RNA Sequencing and Assay include Illumina, Thermo Fisher Scientific, QIAGEN, Takara Bio and NEB, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Micro-RNA Sequencing and Assay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Micro-RNA Sequencing and Assay.
Report Scope
The Micro-RNA Sequencing and Assay market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Micro-RNA Sequencing and Assay market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Micro-RNA Sequencing and Assay companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina
Thermo Fisher Scientific
QIAGEN
Takara Bio
NEB
Segment by Type
Sequencing by Synthesis
Sequencing by Nanopore
Ion Semiconductor Sequencing
Segment by Application
Research Institute
Academia
CRO
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Micro-RNA Sequencing and Assay companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Micro-RNA Sequencing and Assay Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Sequencing by Synthesis
1.2.3 Sequencing by Nanopore
1.2.4 Ion Semiconductor Sequencing
1.3 Market by Application
1.3.1 Global Micro-RNA Sequencing and Assay Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research Institute
1.3.3 Academia
1.3.4 CRO
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Micro-RNA Sequencing and Assay Market Perspective (2019-2030)
2.2 Micro-RNA Sequencing and Assay Growth Trends by Region
2.2.1 Global Micro-RNA Sequencing and Assay Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Micro-RNA Sequencing and Assay Historic Market Size by Region (2019-2024)
2.2.3 Micro-RNA Sequencing and Assay Forecasted Market Size by Region (2025-2030)
2.3 Micro-RNA Sequencing and Assay Market Dynamics
2.3.1 Micro-RNA Sequencing and Assay Industry Trends
2.3.2 Micro-RNA Sequencing and Assay Market Drivers
2.3.3 Micro-RNA Sequencing and Assay Market Challenges
2.3.4 Micro-RNA Sequencing and Assay Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Micro-RNA Sequencing and Assay Players by Revenue
3.1.1 Global Top Micro-RNA Sequencing and Assay Players by Revenue (2019-2024)
3.1.2 Global Micro-RNA Sequencing and Assay Revenue Market Share by Players (2019-2024)
3.2 Global Micro-RNA Sequencing and Assay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Micro-RNA Sequencing and Assay Revenue
3.4 Global Micro-RNA Sequencing and Assay Market Concentration Ratio
3.4.1 Global Micro-RNA Sequencing and Assay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Micro-RNA Sequencing and Assay Revenue in 2023
3.5 Micro-RNA Sequencing and Assay Key Players Head office and Area Served
3.6 Key Players Micro-RNA Sequencing and Assay Product Solution and Service
3.7 Date of Enter into Micro-RNA Sequencing and Assay Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Micro-RNA Sequencing and Assay Breakdown Data by Type
4.1 Global Micro-RNA Sequencing and Assay Historic Market Size by Type (2019-2024)
4.2 Global Micro-RNA Sequencing and Assay Forecasted Market Size by Type (2025-2030)
5 Micro-RNA Sequencing and Assay Breakdown Data by Application
5.1 Global Micro-RNA Sequencing and Assay Historic Market Size by Application (2019-2024)
5.2 Global Micro-RNA Sequencing and Assay Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Micro-RNA Sequencing and Assay Market Size (2019-2030)
6.2 North America Micro-RNA Sequencing and Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Micro-RNA Sequencing and Assay Market Size by Country (2019-2024)
6.4 North America Micro-RNA Sequencing and Assay Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Micro-RNA Sequencing and Assay Market Size (2019-2030)
7.2 Europe Micro-RNA Sequencing and Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Micro-RNA Sequencing and Assay Market Size by Country (2019-2024)
7.4 Europe Micro-RNA Sequencing and Assay Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Micro-RNA Sequencing and Assay Market Size (2019-2030)
8.2 Asia-Pacific Micro-RNA Sequencing and Assay Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Micro-RNA Sequencing and Assay Market Size by Region (2019-2024)
8.4 Asia-Pacific Micro-RNA Sequencing and Assay Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Micro-RNA Sequencing and Assay Market Size (2019-2030)
9.2 Latin America Micro-RNA Sequencing and Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Micro-RNA Sequencing and Assay Market Size by Country (2019-2024)
9.4 Latin America Micro-RNA Sequencing and Assay Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Micro-RNA Sequencing and Assay Market Size (2019-2030)
10.2 Middle East & Africa Micro-RNA Sequencing and Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Micro-RNA Sequencing and Assay Market Size by Country (2019-2024)
10.4 Middle East & Africa Micro-RNA Sequencing and Assay Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Micro-RNA Sequencing and Assay Introduction
11.1.4 Illumina Revenue in Micro-RNA Sequencing and Assay Business (2019-2024)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Micro-RNA Sequencing and Assay Introduction
11.2.4 Thermo Fisher Scientific Revenue in Micro-RNA Sequencing and Assay Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 QIAGEN
11.3.1 QIAGEN Company Detail
11.3.2 QIAGEN Business Overview
11.3.3 QIAGEN Micro-RNA Sequencing and Assay Introduction
11.3.4 QIAGEN Revenue in Micro-RNA Sequencing and Assay Business (2019-2024)
11.3.5 QIAGEN Recent Development
11.4 Takara Bio
11.4.1 Takara Bio Company Detail
11.4.2 Takara Bio Business Overview
11.4.3 Takara Bio Micro-RNA Sequencing and Assay Introduction
11.4.4 Takara Bio Revenue in Micro-RNA Sequencing and Assay Business (2019-2024)
11.4.5 Takara Bio Recent Development
11.5 NEB
11.5.1 NEB Company Detail
11.5.2 NEB Business Overview
11.5.3 NEB Micro-RNA Sequencing and Assay Introduction
11.5.4 NEB Revenue in Micro-RNA Sequencing and Assay Business (2019-2024)
11.5.5 NEB Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Illumina
Thermo Fisher Scientific
QIAGEN
Takara Bio
NEB

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂